Typhoid Antibody Testing Market Outlook:
Typhoid Antibody Testing Market size was valued at USD 8.42 billion in 2025 and is likely to cross USD 18.52 billion by 2035, expanding at more than 8.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of typhoid antibody testing is assessed at USD 9.04 billion.
The market is estimated to grow on the back of a rapid increase in typhoid cases globally as an instance of poor sanitation practices. According to the report by the World Health Organization (WHO), by 2030, 1.6 billion people around the world are estimated to lack proper safe drinking water and 2.8 billion people are expected to be not able to attain safe sanitation services. Also in Asia Pacific, more than 4 million cases are diagnosed with typhoid every year due to improper sanitation practices.
The global typhoid antibody testing market is also estimated to witness growth owing to the rising government efforts to make people aware of typhoid, develop nursing facilities, and manage the number of cases in their respective regions.
Key Typhoid Antibody Testing Market Insights Summary:
Regional Highlights:
- Asia Pacific typhoid antibody testing market will hold around 41% share by 2035, driven by increasing typhoid cases and government-led awareness initiatives.
- Europe market will secure 29% share by 2035, driven by highly developed hygiene infrastructure and sanitation standards.
Segment Insights:
- The widal test segment in the typhoid antibody testing market is anticipated to secure a 40% share by 2035, fueled by its simplicity, ease of learning, and ability to detect antibodies effectively.
- The hospital segment in the typhoid antibody testing market is projected to capture a 29% share by 2035, driven by the availability of proper medical facilities and advanced treatment technologies.
Key Growth Trends:
- Increased Rate of Morbidity and Mortality
- Government Support to Manage Typhoid Cases
Major Challenges:
- Lacking Early Diagnosis of Enteric Symptoms
- Lack of Awareness Related to Antibody Testing Kits
Key Players: IDL Biotech AB, LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nectar Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., Siemens Healthcare GmbH, NanoEnTek, CerTest Biotec S.L.
Global Typhoid Antibody Testing Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 8.42 billion
- 2026 Market Size: USD 9.04 billion
- Projected Market Size: USD 18.52 billion by 2035
- Growth Forecasts: 8.2% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: Asia Pacific (41% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, China, India, Japan, Germany
- Emerging Countries: China, India, Japan, South Korea, Brazil
Last updated on : 9 September, 2025
Typhoid Antibody Testing Market Growth Drivers and Challenges:
Growth Drivers
- Increased Rate of Morbidity and Mortality – Typhoid is a deadly disease that can kill people at the same time a wide number of people get affected by it. According to the data from the World Health Organization (WHO), around 11 – 20 million people are known to have typhoid disease. In this, between 128,000 and 161,000 people are known to die as a result of the disease every year.
- Government Support to Manage Typhoid Cases – Government authorities in developing countries are supporting initiatives that promote proper sanitization. Developing countries or underdeveloped countries don’t have proper sanitization. Government authorities of the regions have introduced various programs and initiatives for proper sanitization to support the management of typhoid cases. For instance, the “Swachh Bharat Mission” program was initiated by the Indian government and aims to improve sanitation conditions and waste management, as well as the construction of community toilets throughout the country by 2019.
- Increased Collaboration among the Market Players – Several companies have gone through mergers and acquisitions to expand their product portfolios and increase their market share. Growing merger collaboration among the market players is expected to drive the growth of the typhoid antibody testing market in the future. For instance, in 2020 Abbott Laboratories acquired Alere Inc.'s diagnostics business. This included a range of products to test for typhoid antibodies.
Challenges
- Lacking Early Diagnosis of Enteric Symptoms – In 90% of cases it is seen that patients who are suffering from typhoid never get it diagnosed at an early age of symptoms. This is seen highly in Asia Pacific countries.
- Lack of Awareness Related to Antibody Testing Kits
- Patient’s Exposure to Other Antibiotics Before Visiting Healthcare Facility
Typhoid Antibody Testing Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
8.2% |
|
Base Year Market Size (2025) |
USD 8.42 billion |
|
Forecast Year Market Size (2035) |
USD 18.52 billion |
|
Regional Scope |
|
Typhoid Antibody Testing Market Segmentation:
End Users Segment Analysis
The hospital segment in the typhoid antibody testing market is anticipated to garner the largest revenue share of 29% over the forecast period owing to the availability of proper medical facilities on hospital premises and the availability of advanced technologies and treatment. Besides this, the surge in the medical and tourism industry is also projected to generate numerous growth opportunities for the segment in the coming years. As per the Medical Tourism Association, about 14 million people in the world travel to other countries in search of medical care annually. Moreover, fast-paced, advanced technological equipment and people’s trust in a highly qualified professional are estimated to fuel the growth of the segment.
Product Type Segment Analysis
The WIDAL Test segment is projected to hold 40% share of the global typhoid antibody testing market in the forecast year. WIDAL test includes very fewer equipment and can be performed and learned easily. The WIDAL test is an advanced test that checks for antibodies in the body’s reaction to Salmonella typhi which is the core source of typhoid fever. It generally looks for O and H antibodies in the sample blood of patients. Therefore, owing to its advanced characteristics, this segment is expected to witness major growth over the upcoming decades.
Our in-depth analysis of the global typhoid antibody testing market includes the following segments:
|
Product Type |
|
|
End Users |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Typhoid Antibody Testing Market Regional Analysis:
APAC Market Insights
Asia Pacific industry is predicted to account for largest revenue share of 41% by 2035, driven by increase in typhoid cases in the region.This is backed by the increase in typhoid cases in developing countries such as India, China, Bangladesh, Nepal, Vietnam, and Laos. These countries report more than 75% of typhoid cases around the world.
Moreover, various government-led initiatives aiming at managing the number of cases and spreading awareness and preventive measures are some factors that are expected to enhance the market growth in this region. For instance, in 2019, more than 450,000 typhoid cases have been found in Bangladesh, of which about 7,400 cases resulted in death.
European Market Statistics Insights
The typhoid antibody testing market in Europe is poised to hold a significant market share of 29% by the end of 2035, owing to a highly developed healthcare infrastructure that includes fabulous levels of hygiene and sanitization facilities. They have proper personal hygiene products and public hygiene facilities, along with proper drinking water and food, owing to which a very low number of typhoid cases could be seen in this region. As per World Health Organization, Europe accounts for less than 500 cases of typhoid every year.
Typhoid Antibody Testing Market Players:
- IDL Biotech AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- LINEAR CHEMICALS, S.L.U
- Medical Innovation Ventures Sdn Bhd
- Thermo Fisher Scientific
- Nectar Lifesciences Ltd.
- DIALAB GmbH.
- BIOSYSTEMS S.A.
- Siemens Healthcare GmbH
- NanoEnTek
- CerTest Biotec S.L.
Recent Developments
- IDL Biotech AB launched TUBEX TF, a rapid test for typhoid fever in Kenya. Launch took place at Kenya Medical Research Institute in the presence of doctors, pathologists, and representatives from the Ministry of Health.
- BD launched a new automated cytometry system. The system enhances efficiency by reducing the chances of errors and reducing human intervention
- Report ID: 4164
- Published Date: Sep 09, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Typhoid Antibody Testing Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
